Norepinephrine or dopamine for septic shock: Systematic review of randomized clinical trials

Journal of Intensive Care Medicine

Volumn 27, Issue 3, 2012, Pages 172-178

  Vasu, Tajender S ^a   Cavallazzi, Rodrigo ^a   Hirani, Amyn ^a   Kaplan, Gary ^b   Leiby, Benjamin ^a   Marik, Paul E ^c  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

dopamine; meta analysis; norepinephrine; septic shock; systematic review; vasopressor

Indexed keywords

DOPAMINE; NORADRENALIN;

COCHRANE LIBRARY; CRITICALLY ILL PATIENT; EMBASE; HEART ARRHYTHMIA; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MEDLINE; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEPTIC SHOCK; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW;

ADULT; DOPAMINE; DOPAMINE AGENTS; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; NOREPINEPHRINE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SHOCK, SEPTIC; VASCULAR RESISTANCE; VASOCONSTRICTOR AGENTS;

EID: 84860723131     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066610396312     Document Type: Review

References (31)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR.. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001 ; 29 (7). 1303-1310 (Pubitemid 32641789)
2. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008 ; 36 (1). 296-327
3. Martin C, Viviand X, Leone M, Thirion X.. Effect of norepinephrine on the outcome of septic shock. Crit Care Med. 2000 ; 28 (8). 2758-2765
4. Sakr Y, Reinhart K, Vincent JL, et al. Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study. Crit Care Med. 2006 ; 34 (3). 589-597
5. Povoa PR, Carneiro AH, Ribeiro OS, et al. Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study). Crit Care Med. 2009 ; 37 (2). 410-416
6. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009 ; 151 (4). W65 - W94
7. Higgins JPT AD. Cochrane Handbook for Systematic Reviews of Interventions. Higgins JPT Green S, ed.
8. Watson D, Grover R, Anzueto A, et al. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002). Crit Care Med. 2004 ; 32 (1). 13-20 (Pubitemid 38125558)
9. Simon Grahe JJ, Patel GP, Elpern E,, et al. The safety of dopamine versus norepinephrine as vasopressor therapy in septic shock (Abstract). Chest. 2005 ; 128: 219S - 220S
10. Schreuder WO, Schneider AJ, Groeneveld AB, Thijs LG.. Effect of dopamine vs norepinephrine on hemodynamics in septic shock. Emphasis on right ventricular performance. Chest. 1989 ; 95 (6). 1282-1288 (Pubitemid 19160158)
11. Wu LJ, He QY, Li G, et al. Effect of dopamine and norepinephrine on hemodynamics and tissue oxygenation of patients with septic shock. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2008 ; 20 (1). 18-22 (Pubitemid 351233524)
12. Martin C, Papazian L, Perrin G, Saux P, Gouin F.. Norepinephrine or dopamine for the treatment of hyperdynamic septic shock?. Chest. 1993 ; 103 (6). 1826-1831 (Pubitemid 23174321)
13. Ruokonen E, Takala J, Kari A, et al. Regional blood flow and oxygen transport in septic shock. Crit Care Med. 1993 ; 21 (9). 1296-1303 (Pubitemid 23270498)
14. Marik PE, Mohedin M.. The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. JAMA. 1994 ; 272 (17). 1354-1357 (Pubitemid 24323617)
15. Mathur SK, Dhunna R, Chakraborty A.. Comparison of norepinephrine and dopamine in the management of septic shock using impedance cardiography. Indian J Crit Care Med. 2007 ; 1 (5). 186-191
16. Patel GP, Grahe JS, Sperry M, et al. Efficacy and safety of dopamine versus norepinephrine in the management of septic shock. Shock. 2010 ; 33 (4). 375-380
17. De Backer D, Biston P, Devriendt J, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010 ; 362 (9). 779-789
18. Mullner M, Urbanek B, Havel C, et al. Vasopressors for shock. Cochrane Database Syst Rev. 2004 ; (3). CD003709
19. Treggiari MM, Romand JA, Burgener D, et al. Effect of increasing norepinephrine dosage on regional blood flow in a porcine model of endotoxin shock. Crit Care Med. 2002 ; 30 (6). 1334-1339 (Pubitemid 34620981)
20. Jhanji S, Stirling S, Patel N, Suter PM, Aneman A.. The effect of increasing doses of norepinephrine on tissue oxygenation and microvascular flow in patients with septic shock. Crit Care Med. 2009 ; 37 (6). 1961-1966
21. Bailey AR, Burchett KR.. Effect of low-dose dopamine on serum concentrations of prolactin in critically ill patients. Br J Anaesth. 1997 ; 78 (1). 97-99 (Pubitemid 27047424)
22. Van den Berghe G, de Zegher F, Lauwers P.. Dopamine and the sick euthyroid syndrome in critical illness. Clin Endocrinol (Oxf). 1994 ; 41 (6). 731-737
23. Van den Berghe G, de Zegher F, Lauwers P.. Dopamine suppresses pituitary function in infants and children. Crit Care Med. 1994 ; 22 (11). 1747-1753 (Pubitemid 24346028)
24. Reichlin S.. Neuroendocrine-immune interactions. N Engl J Med. 1993 ; 329 (17). 1246-1253
25. Santambrogio L, Lipartiti M, Bruni A, et al. Dopamine receptors on human T- and B-lymphocytes. J Neuroimmunol. 1993 ; 45 (1-2). 113-119
26. Kouassi E, Li YS, Boukhris W, Revillard JP.. Opposite effects of the catecholamines dopamine and norepinephrine on murine polyclonal B-cell activation. Immunopharmacology. 1998 ; 16 (3). 125-137
27. Bergquist J, Josefsson E, Tarkowski A, Ekman R, Ewing A.. Measurements of catecholamine-mediated apoptosis of immunocompetent cells by capillary electrophoresis. Electrophoresis. 1997 ; 18 (10). 1760-1766 (Pubitemid 27451830)
28. Josefsson E, Bergquist J, Ekman R, Tarkowski A.. Catecholamines are synthesized by mouse lymphocytes and regulate function of these cells by induction of apoptosis. Immunology. 1996 ; 88 (1). 140-146 (Pubitemid 26166387)
29. Oberbeck R, Schmitz D, Wilsenack K, et al. Dopamine affects cellular immune functions during polymicrobial sepsis. Intensive Care Med. 2006 ; 32 (5). 731-739
30. Devins SS, Miller A, Herndon BL, O'Toole L, Reisz G.. Effects of dopamine on T-lymphocyte proliferative responses and serum prolactin concentrations in critically ill patients. Crit Care Med. 1992 ; 20 (12). 1644-1649
31. Rudis MI, Basha MA, Zarowitz BJ.. Is it time to reposition vasopressors and inotropes in sepsis?. Crit Care Med. 1996 ; 24 (3). 525-537 (Pubitemid 26097849)